A protein that breast, lung and other cancers use to promote their spread—or metastasis—to the brain, has been identified by a team led by Weill Cornell Medicine and New York-Presbyterian investigators. The protein, CEMIP, ...
Nov 4, 2019
0
82
In 2018, breast cancer was the most common cancer in women worldwide, accounting for about a quarter of all reported cancers. When breast cancer metastasizes, the brain is a common destination.
Sep 18, 2019
0
54
Metastasizing breast cancers typically seek out the bones, lung, and brain. Brain metastases are especially dangerous; many women survive for less than a year after diagnosis. How is the cancer able to get past the blood ...
Sep 12, 2019
0
176
Brain metastases are among the deadliest tumor metastases, with a median survival period of less than one year, and the incidence of brain metastasis is rising.
Aug 19, 2019
0
2261
Melanoma tumors that have spread to the brain are equipped to thwart immunotherapies and targeted therapies that succeed against tumors growing in other sites. Researchers at The University of Texas MD Anderson Cancer Center ...
Feb 20, 2019
0
6
Cancer used to be thought of as a disease of the anatomy, but these days it increasingly is understood as a disease of the genes—one that theoretically can be treated with drugs engineered to target the genetic mutations ...
Nov 15, 2018
0
1
When melanoma turns metastatic, it spreads to the brain in more than 40% of patients. A study by Yale Cancer Center researchers published today in the Journal of Clinical Oncology (JCO) shows a checkpoint inhibitor immunotherapy ...
Nov 9, 2018
0
85
Results of a 275-patient, multi-national phase III clinical trial known as ALTA-1L published today in the New England Journal of Medicine and presented concurrently in the press program at the International Association for ...
Sep 25, 2018
0
5
Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer (NSCLC) presented on the press program of the International Association for the Study of Lung Cancer (IASLC) ...
Sep 24, 2018
0
1
Combination immunotherapy shrank melanoma that has spread to the brain in more than half of the patients in a clinical trial reported in the New England Journal of Medicine led by an investigator at The University of Texas ...
Aug 22, 2018
0
355
